@xconomy.com 3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com 5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com 5 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up
@venturebeat.com 7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs